procedure in which radiation-eluting microspheres are delivered to liver tumors through the hepatic arteries, my focus has evolved into a broader interest in image-guided cancer therapies through the framework of a multidisciplinary care team. That said, I enjoy everything we do as a specialty, such as interacting with patients and physicians across most medical disciplines. IR is an innovative, rapidly changing specialty.
How did you get involved with SIR? RL: I have been involved with SIR for most of my career, much like the 800+ volunteers currently serving our society, promoting a strong, healthy specialty. I became more invested in SIR volunteerism in 2014 when I was invited to join the Annual Meeting Committee (AMC), a 4-year commitment tasked with developing the structure and agenda of our annual scientific meeting, the premiere event of our society that annually attracts around 5,000 attendees. I was chair of the SIR 2017 Annual Scientific Meeting in Washington, D.C. This experience on the AMC allowed me to collaborate with colleagues across the country, SIR staff, industry partners and other physician volunteers. I was struck by the talent and passion that exists within our specialty and society. When my time on the AMC ended, I sought other volunteer opportunities within SIR, which led me to my current position.
As SIR president, what will be your main priorities for next year? RL: I think it is important to clarify that being the society’s president isn’t truly a 1-year experience. Rather, it’s a 4-year commitment, starting as secretary. This provides consistency to the ongoing priorities, which are a collaboration between the secretary, president- elect, president, immediate past president and SIR Executive Director. With a commitment to serving all SIR members, we will be striving to move our specialty forward as an independent medical specialty providing minimally invasive image-guided therapies and comprehensive longitudinal patient care. Currently, my focus is on initiating the
Foundation can hasten the transition of IR into a clinical specialty focused on the longitudinal care of our patients through several means. These include providing education and resources for SIR members throughout all stages of their careers, facilitating and funding research that delivers the evidence required to support our practices, developing metrics that demonstrate the value of IR to healthcare systems, and advocating for the acceptance and reimbursement of minimally invasive image-guided therapies.
Robert J. Lewandowski, MD, FSIR
Despite years of progress, several factors remain that limit many interventional radiologists in their desire to provide comprehensive longitudinal care of their patients. SIR and SIR Foundation can hasten the transition of IR into a clinical specialty focused on the longitudinal care of our patients through several means.
search for our next executive director. In this process, we strive to continue our organizational evolution and embrace this as an opportunity to bring in fresh and dynamic perspectives.
What do you think is currently one of the greatest challenges facing IR and how can SIR and SIR Foundation address it? RL: Despite years of progress, several factors remain that limit many interventional radiologists in their desire to provide comprehensive longitudinal care of their patients. SIR and SIR
We’re coming up on the 50th anniversary of the SIR. There have been incredibly impactful accomplishments during the last 50 years, such as the primary specialty designation and the IR Residency. What do you think is the next opportunity that the SIR and IR should be striving toward? RL: The 50th anniversary of SIR is a huge milestone, with many accomplishments to celebrate and many opportunities to explore. To pick just one such opportunity, I believe SIR should strive toward creating subspecialty training to facilitate our members becoming disease-specific multidisciplinary team members and leaders. This message of the natural evolution of our specialty was elegantly delivered through Dr. William Rilling’s Dotter Lecture at the 2023 SIR Annual Scientific Meeting, and it mirrors our new governance structure with domain-specific clinical specialty councils having significant input into our strategic mission.
What are you most excited about as you enter your presidency? RL: As I enter my presidency, I’m most excited to continue my work with colleagues and friends, pursuing opportunities for the SIR to empower its members to positively impact patients’ lives through image-guided procedures. My vision is that one day, all patients in every corner of the globe will have knowledge of and access to our image- guided therapies.
irq.sirweb.org | 7
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40
